Combined Medication and Dialectical Behavior Therapy for Borderline Personality Disorder

S. Charles Schulz, Michael P. Rafferty

Research output: Chapter in Book/Report/Conference proceedingChapter


Medication treatment for BPD has developed in recent years as interest in pharmacotherapy of BPD has increased and as new medications have become available. With these developments has come the need for those clinicians working with BPD patients to learn and practice working together. This chapter reviews the pharmacotherapy options for patients with BPD so that all clinicians on a treatment team may be acquainted with the data supporting medication intervention. Following the section on medication, there is a discussion of DBT, an empirically supported psychotherapy now commonly used for the treatment of BPD. A description of how the treatment team can work together is offered. Because some BPD patients may provide challenges due to a tendency toward splitting, this integrated approach may lead to better treatment outcomes.

Original languageEnglish (US)
Title of host publicationBorderline Personality Disorder
Subtitle of host publicationMeeting the Challenges to Successful Treatment
PublisherTaylor and Francis
Number of pages12
ISBN (Electronic)9781136867590
ISBN (Print)9780203837016
StatePublished - Jan 1 2012


  • Borderline personality disorder
  • dialectical behavioral therapy
  • psychotropic medications
  • treatment team

ASJC Scopus subject areas

  • Psychology(all)
  • Social Sciences(all)


Dive into the research topics of 'Combined Medication and Dialectical Behavior Therapy for Borderline Personality Disorder'. Together they form a unique fingerprint.

Cite this